Recalls dent Stryker Q1 earnings

Recalls helped sink first-quarter numbers for medical device maker Stryker. Modern Healthcare reports that the company saw earnings fall 77% for the quarter ended March 30 compared to the same period last year.

Sales, however, rose to $2.31 billion, a 5% bump compared to the same period a year ago.

As Modern Healthcare reports, $344 million in charges related to recalls of Rejuvenate and ABG II modular-neck hip stems inflicted the the 77% earnings dent. Sales rose in the company's core categories: reconstructive, medical-surgical and neurotechnology, and spine.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.